SCHEMBL6587420

SCHEMBL6587420

CCCCCCCC([C]=O)CC

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.43
GPR84 Q9NQS5 5/20 0.40
FDPS P14324 3/20 0.40
FFAR1 O14842 1/20 0.40
LMNA P02545 1/20 0.39
LCK P06239 1/20 0.39
PPARD Q03181 1/20 0.39
ZDHHC20 Q5W0Z9 1/20 0.39
ZDHHC2 Q9UIJ5 1/20 0.39
DNM1 Q05193 1/20 0.39
TSHR P16473 1/20 0.38
THRB P10828 1/20 0.38
ADH1B P00325 1/20 0.38
ADH1C P00326 1/20 0.38
ADH1A P07327 1/20 0.38
ADH4 P08319 1/20 0.38
ADH7 P40394 1/20 0.38
LAP3 P28838 1/20 0.38
CA2 P00918 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL137130 1.00 MAPT (0.43) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL5160091 1.00 MAPT (0.43) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL9233916 1.00 MAPT (0.43) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL8648044 1.00 MAPT (0.43) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL8646134 1.00 MAPT (0.43) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL5154559 1.00 MAPT (0.43) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL8647947 1.00 MAPT (0.43) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL8647983 1.00 MAPT (0.43) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL8650122 1.00 MAPT (0.43) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL1410679 1.00 MAPT (0.43) MAPTGPR84FDPSFFAR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115996929-A Antagonists of adenosine A2a receptors 阿道尔克斯治疗有限公司 2023-04-21 CN claimed
CN-113395965-A USP19 inhibitors for treatment 阿尔麦克探索有限公司 2021-09-14 CN claimed
EP-3041842-A1 SPIROCYCLIC COMPOUNDS AS TRYPTOPHAN HYDROXYLASE INHIBITORS Karos Pharmaceuticals, Inc. (US) 2016-07-13 EP claimed
WO-2015035113-A1 SPIROCYCLIC COMPOUNDS AS TRYPTOPHAN HYDROXYLASE INHIBITORS KAROS PHARMACEUTICALS, INC. (US) 2015-03-12 WO claimed
WO-2024146502-A1 WEE1 DEGRADING COMPOUNDS BEIJING NEOX BIOTECH LIMITED (CN) 2024-07-11 WO disclosed
CN-116916924-A MALT1 modulators and uses thereof 稀有生物科学股份有限公司 2023-10-20 CN disclosed
CN-115996929-A Antagonists of adenosine A2a receptors 阿道尔克斯治疗有限公司 2023-04-21 CN disclosed
CN-109790146-B Pharmaceutical compounds 阿尔麦克探索有限公司 2022-08-23 CN disclosed
CN-113395965-A USP19 inhibitors for treatment 阿尔麦克探索有限公司 2021-09-14 CN disclosed
CN-108601769-B Pyrazole compounds and methods of making and using the same H.隆德贝克有限公司 2021-09-03 CN disclosed
WO-2021126725-A1 NOVEL SUBSTITUTED 1,3,8-TRIAZASPIRO[4,5]DECANE-2,4-DIONE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) AND/OR TRYPTOPHAN 2,3-DIOXYGENASE (TDO) INHIBITORS MERCK SHARP & DOHME CORP. (US) 2021-06-24 WO disclosed
EP-3704121-A1 DIAZASPIRO ROCK INHIBITORS Bristol-Myers Squibb Company (US) 2020-09-09 EP disclosed
CN-101111483-B IGF-1R inhibitors KYOWA HAKKO KIRIN CO.,LTD. (JP) 2011-12-14 CN disclosed
CN-101460462-A Spirocyclic nitriles as protease inhibitors SANOFI AVENTIS (FR) 2009-06-17 CN disclosed
CN-101111483-A IGF-1R inhibitors KYOWA HAKKO KOGYO KK (JP) 2008-01-23 CN disclosed
CN-1890238-A Hydronopol derivatives as agonists on human ORL1 receptors SOLVAY PHARM GMBH (DE) 2007-01-03 CN disclosed
EP-1379506-A2 SUBSTITUTED CARBOXAMIDES ELI LILLY AND COMPANY (US) 2004-01-14 EP disclosed
WO-2002064567-A2 SUBSTITUTED CARBOXAMIDES AS INHIBITORS OF FACTOR XA ELI LILLY AND COMPANY (US) 2002-08-22 WO disclosed
EP-1140903-A1 AROMATIC AMIDES ELI LILLY AND COMPANY (US) 2001-10-10 EP disclosed
WO-2000039118-A1 AROMATIC AMIDES ELI LILLY AND COMPANY (US) 2000-07-06 WO disclosed